Cell-permeable peptide inhibitors of the JNK signal transduction pathway

Details for Australian Patent Application No. 2003201733 (hide)

Owner University of Lausanne

Inventors Bonny, Christophe

Agent Cullen & Co

Pub. Number AU-B-2003201733

PCT Number PCT/IB03/00332

PCT Pub. Number WO2003/057725

Priority 60/347,062 09.01.02 US

Filing date 9 January 2003

Wipo publication date 24 July 2003

Acceptance publication date 6 November 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/48 (2006.01) Drugs for disorders of the endocrine system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/347,062 09.01.02 US

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2003201733

6 November 2008 Application Accepted

  Published as AU-B-2003201733

18 December 2008 Assignment before Grant

  University of Lausanne The application has been assigned to Xigen SA

5 March 2009 Standard Patent Sealed

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003201734-PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS DISPERSIONS OF DRUGS AND LIPOPHILIC MICROPHASE-FORMING MATERIALS

2003201732-POMPE AIDAM-DANGBO